Cargando…
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience
The emerging outbreak of the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread worldwide. We prescribed some promising medication to our patients with mild to moderate pneumonia due to SARS-CoV-2, however such drugs as...
Autores principales: | Tascini, Carlo, Sermann, Giovanni, Pagotto, Alberto, Sozio, Emanuela, De Carlo, Chiara, Giacinta, Alessandro, Sbrana, Francesco, Ripoli, Andrea, Castaldo, Nadia, Merelli, Maria, Cadeo, Barbara, Macor, Cristiana, De Monte, Amato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603641/ https://www.ncbi.nlm.nih.gov/pubmed/33131033 http://dx.doi.org/10.1007/s11739-020-02542-6 |
Ejemplares similares
-
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply
por: De Monte, Amato, et al.
Publicado: (2021) -
CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial
por: Sozio, Emanuela, et al.
Publicado: (2021) -
MR-proADM as prognostic factor of outcome in COVID-19 patients
por: Sozio, Emanuela, et al.
Publicado: (2021) -
Recognition in Emergency Department of Septic Patients at Higher Risk of Death: Beware of Patients without Fever
por: Sozio, Emanuela, et al.
Publicado: (2021) -
MAGLIO study: epideMiological Analysis on invasive meninGococcaL disease in Italy: fOcus on hospitalization from 2015 to 2019
por: Tascini, Carlo, et al.
Publicado: (2023)